NF0 Pill - white capsule/oblong, 19mm
Pill with imprint NF0 is White, Capsule/Oblong and has been identified as Metformin Hydrochloride Extended-Release 1000 mg. It is supplied by Nostrum Laboratories, Inc.
Metformin is used in the treatment of Type 2 Diabetes and belongs to the drug class non-sulfonylureas. There is no proven risk in humans during pregnancy. Metformin 1000 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for NF0
Metformin Hydrochloride Extended-Release
- Imprint
- NF0
- Strength
- 1000 mg
- Color
- White
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Non-sulfonylureas
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Nostrum Laboratories, Inc.
- National Drug Code (NDC)
- 29033-0032
- Inactive Ingredients
-
lactose monohydrate,
stearic acid,
microcrystalline cellulose,
silicon dioxide,
oleic acid,
ethylcellulose,
ammonia,
magnesium silicate,
hypromellose 2208 (100000 mPa.s),
polyethylene glycol 400,
medium-chain triglycerides,
povidone,
xanthan gum,
titanium dioxide,
triacetin
Note: Inactive ingredients may vary.
Related images for "NF0"
More about metformin
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (653)
- Drug images
- Latest FDA alerts (18)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: non-sulfonylureas
- Breastfeeding
Patient resources
- Metformin drug information
- Metformin Extended-Release Tablets
- Metformin Extended-Release Suspension
- Metformin Oral Solution
Other brands
Glucophage, Glumetza, Glucophage XR, Fortamet, ... +2 more
Professional resources
- MetFORMIN monograph
- Metformin (FDA)
- Metformin Extended Release Tablet (FDA)
- Metformin Extended Release Tablets (FDA)
- Metformin Oral Solution (FDA)
Other brands
Glucophage, Glumetza, Glucophage XR, Fortamet, Riomet
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.